Skip to main navigation Skip to search Skip to main content
  • 723
    Citations
20142022

Research activity per year

Personal profile

Research interests

Translational research in esophagogastric carcinoma

I coordinate 5 clinical trials wherein I also perform translational research

ACTION: a phase Ib study on the addition of Nab-Paclitaxel to capecitabine and oxaliplatin in the first line treatment of metastatic esophagogastric carcinoma

PERFECT: PDL-1 targetin in resectable esophageal cancer: a phase II feasibility study of Atezolizumab and chemoradiation

REPEAT: Regorafenib in combination with paclitaxel in advanced esophagogastric carcinoma, a phase 1b study

SOX: feasibility study of adjuvant treatment with S-1 and oxaliplatin in patients with resectable esophageal cancer

TRAP: feasibility study of chemoradiation, Trastuzumab and Pertuzumab in resectable HER2+ esophageal carcinoma

Specialisation

Medical Oncology: translational research in esophagogastric carcinoma

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics where Sandor Schokker is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or